Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 62
Published on September 23, 2016 at 09:30 AM


About Fast Acting Insulin Drug NovoRapid

European drug committee issued positive assessment for the usage of NovoRapid drug (manufactured by Danish company Novo Nordisk) for the diabetes treatment to children above 1 year. NovoRapid is an Insulin aspart, a fast acting insulin which can be absorbed quickly into blood stream. European Commission may issue final regulatory decision within two months.


       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Discovery Of Fast Acting Insulin Of Conus Geographus
2. Discovery Gene Destroying Insulin Producing Cells
3. Device To Release Drugs In Eye
4. Device To Predict Diabetes
5. Trials Of GLP-1 (exenatide extended-release) And Farxiga (dapagliflozin)

NovoRapid : NovoRapid (insulin aspart) drug manufactured by Novo Nordisk to treat diabetes for an individual over two years. This drug is available in more than 120 countries.

Novo Nordisk : Novo Nordisk is a multinational pharmaceutical company having headquarters in Denmark. They market products under the brands Novolin R, Levemir, NovoSeven, NovoLog, NovoEight and Victoza. Key products of the company are

 

Link Between Gestational Diabetes And Depression

A study done by researchers from the National Institutes of Health says two way link exists between depression and diabetes and both of them occur together. But the study failed to show cause and relationship between depression and diabetes. Researchers analyzed 2,477 pregnant women data and found that

Dr Stefanie Hinkle participated in the research work, a staff scientist in the Division of Intramural Population Health Research and the study results were published in the journal Diabetologia.


       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Study Of Gestational Diabetes (GD)
2. Risks With Gestational Diabetes After Birth
3. Genetic Link Between Diabetes And Depression
4. Diabetes Link To Depression
5. Storing Body Fat More efficiently

Trimesters : Trimester is a measure of pregnancy. Pregnancy period (40 weeks) contains three trimesters. They are

 

About Continuous Glucose Monitoring (CGM) Devices
Global Continuous Glucose Monitoring (CGM) devices market is dominated by Abbott Laboratories, DexCom Incorporation and Medtronic. Continuous Glucose Monitoring (CGM) devices are for type i diabetes (T1D) patients as they face risks with hypoglycemia and hyperglycemia conditions and early detection of them is required. Usage of CGM devices are increasing due to increase in the population of patients with type 1 diabetes (T1D), obesity and sedentary lifestyle of humans. Manufactures are facing some challenges as they could not able to improve accuracy in the CGM data. Available CGM devices in the market are

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Devices To Read Glucose Levels In Perspiration
2. Devices From Medtronic
3. About Cybersecurity For Diabetes Devices
4. Device To Detect Deadly Ketones
5. About Revita DMR Device

Continuous glucose monitoring : Continuous glucose monitoring (CGM) devices measure an individual's glucose levels in real time continuously. These devices measure glucose levels from the fluid in and around your skin cells and not from blood stream. CGM devices are less invasive. A disposable glucose sensor inserted in tissue fluid under skin reads glucose levels. A wireless transmitter is connected to the glucose sensor to send data to signal receiver and display device. Diabetes patients and health care professionals can get better and complete picture on sugar levels with CGMs and helps in taking prompt and better decisions on medications. Some CGM devices even alert patient before sugar levels reach limits. The 2015 NICE guidelines for the management of type 1 diabetes (T1D) recommends usage of CGM devices for type 1 diabetes (T1D) as they suffer with hypoglycemia.

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.